Advertisement

Digestive Diseases and Sciences

, Volume 57, Issue 4, pp 858–864 | Cite as

Enhanced Gastric Ghrelin Production and Secretion in Rats with Gastric Outlet Obstruction

  • Eisuke Iwasaki
  • Hidekazu SuzukiEmail author
  • Tatsuhiro Masaoka
  • Toshihiro Nishizawa
  • Hiroshi Hosoda
  • Kenji Kangawa
  • Toshifumi Hibi
Original Article

Abstract

Background and Aim

Ghrelin has distinct effects on gastrointestinal motility through the vagus nerve and gastric excitatory neural plexus. The objectives of this study were to investigate the dynamics of ghrelin and expression of neuromuscular markers in a newly established surgically manipulated rat model of gastric outlet obstruction (GOO), akin to the pyloric stricture associated with duodenal ulcer, advanced gastric cancer, and other conditions, in the clinical setting.

Material and Methods

The rats were divided into two groups, a control group (sham operation) and the GOO group (proximal duodenal stricture). The animals were sacrificed 2 weeks after the operation. Plasma and gastric ghrelin were measured by radioimmunoassay. mRNA expression in the stomach of neural choline acetyltransferase (ChAT), c-kit, and membrane-bound stem cell factor (SCF) were analyzed by quantitative RT-PCR. In addition, gastric mRNA expression of the aforementioned were also evaluated 60 min after intraperitoneal administration of a synthetic GHS-R1a antagonist ([d-Lys3] GHRP-6 6.0 mg/kg).

Results

Mechanical GOO induced increases of fasting plasma ghrelin levels and hyperplasia of the gastric muscle layers, with enhanced expression of the gastric neuromuscular markers. Administration of [d-Lys3] GHRP-6 normalized the enhanced expression of c-kit and SCF.

Conclusion

GOO stimulates ghrelin dynamics and then enhances the mechanistic expression of gastric cellular communication network molecules between nerves and smooth muscle cells.

Keywords

Ghrelin Gastric emptying Motility Gastric outlet obstruction 

Notes

Acknowledgments

This work was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (no. 18790471 to EI), a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (no. 22300169, to HS), a Health and Labour Sciences Research Grant for Research on Health Technology Assessment (Clinical Research Promotion no. 47 to HS), a grant from the JSPS Bilateral Joint Projects with Belgium (11035231-000061), a grant from the Smoking Research Foundation (to HS), the Keio Gijuku Academic Development Fund (to HS), and a Nateglinide Memorial Toyoshima Research and Education Fund (to HS).

References

  1. 1.
    Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660.PubMedCrossRefGoogle Scholar
  2. 2.
    Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–908.PubMedCrossRefGoogle Scholar
  3. 3.
    Xu L, Depoortere I, Tomasetto C, et al. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept. 2005;124:119–125.PubMedCrossRefGoogle Scholar
  4. 4.
    De Winter BY, De Man JG, Seerden TC, et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil. 2004;16:439–446.PubMedCrossRefGoogle Scholar
  5. 5.
    Fujino K, Inui A, Asakawa A, et al. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol. 2003;550:227–240.PubMedCrossRefGoogle Scholar
  6. 6.
    Chasen M, Bhargava R. Gastrointestinal symptoms, electrogastrography, inflammatory markers, and pg-sga in patients with advanced cancer. Support Care Cancer. 2011 [Epub ahead of print].Google Scholar
  7. 7.
    Nishizawa T, Suzuki H, Nomoto Y, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther. 2006;24(Suppl 4):104–110.Google Scholar
  8. 8.
    Ohnishi N, Okada K, Yoshioka M, et al. Studies on interactions between traditional herbal and western medicines. V. Effects of sho-saiko-to (xiao-cai-hu-tang) on the pharmacokinetics of carbamazepine in rats. Biol Pharm Bull. 2002;25:1461–1466.PubMedCrossRefGoogle Scholar
  9. 9.
    Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341–3350.PubMedCrossRefGoogle Scholar
  10. 10.
    Hosoda H, Kojima M, Matsuo H, et al. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909–913.PubMedCrossRefGoogle Scholar
  11. 11.
    Masaoka T, Suzuki H, Hosoda H, et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett. 2003;541:64–68.PubMedCrossRefGoogle Scholar
  12. 12.
    Bisschops R. Ligand and electrically induced activation patterns in myenteric neuronal networks. Confocal calcium imaging as a bridge between basic and human physiology. Verh K Acad Geneeskd Belg. 2008;70:105–145.PubMedGoogle Scholar
  13. 13.
    Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183–186.PubMedCrossRefGoogle Scholar
  14. 14.
    Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in mongolian gerbils. Gut. 2004;53:187–194.PubMedCrossRefGoogle Scholar
  15. 15.
    Izbeki F, Wittman T, Rosztoczy A, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192–198.PubMedCrossRefGoogle Scholar
  16. 16.
    Suzuki S, Suzuki H, Horiguchi K, et al. Delayed gastric emptying and disruption of the interstitial cells of cajal network after gastric ischaemia and reperfusion. Neurogastroenterol Motil. 2010;22:585–593, e126.Google Scholar
  17. 17.
    Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Eisuke Iwasaki
    • 1
    • 2
  • Hidekazu Suzuki
    • 1
    Email author
  • Tatsuhiro Masaoka
    • 1
  • Toshihiro Nishizawa
    • 1
  • Hiroshi Hosoda
    • 3
  • Kenji Kangawa
    • 3
  • Toshifumi Hibi
    • 1
  1. 1.Division of Gastroenterology and Hepatology, Department of Internal MedicineKeio University School of MedicineShinjuku-kuJapan
  2. 2.Department of Internal MedicineSaiseikai Central HospitalMinato-kuJapan
  3. 3.Department of BiochemistryNational Cardiovascular Center Research InstituteSuitaJapan

Personalised recommendations